Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -1.50 (-4.69%)
Bid:
29.00
Ask:
32.00
Spread: 3.00 (10.345%)
Market Cap: £2.94m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Agreement with the FSA

24 Feb 2012 07:00

RNS Number : 0550Y
CPPGroup Plc
24 February 2012
 



CPPGroup plc - Agreement with the FSA

24 February 2012

Further to the announcement on 20th February, CPPGroup plc ("CPP" or the "Group") announces that it has reached agreement in principle with the FSA in relation to the scope of actions necessary to address certain failings in CPP's sales processes.

In relation to both its Card Protection and Identity Protection products, CPP has agreed with the FSA to undertake a past business review whereby CPP will contact customers whom CPP approached directly to purchase the products.

CPP has also agreed to implement with FSA oversight a number of changes to its renewals process, in order to highlight more clearly to customers that they have the right not to renew the product, and to explain clearly to the customer the advantages and limitations of the relevant product. CPP will now work with the FSA to agree the detail of these proposals.

Further, CPP has agreed to certain restrictions on the disposition of assets, including in relation to the payment of dividends. In particular, shareholders should be aware that the Group will not declare or pay any final dividend in respect of the financial year ended 31 December 2011.

CPP considers this agreement to be a positive development. The resolution of these issues allows CPP to renew its focus on evolving towards a more customer centric business.

In assessing the likely financial impact, CPP has with its advisors considered a number of assumptions, including as to customer response rates to the past business review and any impact on renewal take up rates. Based on those initial assumptions, CPP estimates that the financial exposure of the Group resulting from customer compensation, potential loss of renewal business and costs associated with carrying out the past business review, is expected be in the range of £10 million to £15 million.

CPP remains in discussions with various stakeholders, including its financing banks and business partners, as to the ultimate impact on the business of the FSA's investigation. Until those discussions have concluded it is expected that the suspension of CPP's shares remains in place.

Further announcements will be made in due course.

 

Enquiries:

 

Paul Stobart, Group Chief Executive

Shaun Parker, Chief Financial Officer

Tel. +44 (0)20 7353 4200 (today)

Tel: +44 (0)1904 544702 (thereafter)

 

Tulchan Communications

John Sunnucks

David Allchurch

Martin Robinson

Tel. +44 (0)20 7353 4200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLIFFRFSISFIF
Date   Source Headline
11th Sep 20198:43 amRNSBusiness Update
9th Sep 20193:44 pmRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSHalf-year Report
12th Aug 20194:09 pmRNSBlock listing Interim Review
1st Jul 20194:30 pmRNSTotal Voting Rights
1st Jul 20194:21 pmRNSBlock listing Interim Review
17th Jun 20192:36 pmRNSDirector/PDMR Shareholding
30th May 20194:41 pmRNSSecond Price Monitoring Extn
30th May 20194:35 pmRNSPrice Monitoring Extension
15th May 201910:09 amRNSPresentation at MELLO 2019
8th May 20199:36 amRNSAGM Statement
1st May 20193:39 pmRNSTotal Voting Rights
30th Apr 20193:39 pmRNSDirector/PDMR Shareholding
12th Apr 20199:56 amRNSAGM Statement
1st Apr 201910:17 amRNSTotal Voting Rights
27th Mar 20194:41 pmRNSSecond Price Monitoring Extn
27th Mar 20194:35 pmRNSPrice Monitoring Extension
27th Mar 20197:00 amRNSFinal Results
13th Mar 20192:25 pmRNSNotice of Results
12th Feb 201911:06 amRNSBlock listing Interim Review
4th Feb 20193:47 pmRNSTotal Voting Rights
21st Dec 20183:27 pmRNSDirector/PDMR Shareholding
21st Dec 20183:27 pmRNSDirector/PDMR Shareholding
20th Dec 20183:50 pmRNSDirector/PDMR Shareholding
20th Dec 20189:56 amRNSDirector/PDMR Shareholding
18th Dec 20182:48 pmRNSBlock listing Interim Review
5th Dec 20184:18 pmRNSHolding(s) in Company
4th Dec 20182:09 pmRNSTotal Voting Rights
1st Nov 20183:42 pmRNSTotal Voting Rights
2nd Oct 201812:41 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSHalf-year Report
13th Sep 20187:00 amRNSCPP investment boosts growth ambitions in India
3rd Sep 20184:57 pmRNSTotal Voting Rights
22nd Aug 20183:15 pmRNSAdditional Listing
13th Aug 20184:42 pmRNSBlock listing Interim Review
2nd Aug 20185:04 pmRNSTotal Voting Rights
11th Jul 20189:10 amRNSTotal Voting Rights
20th Jun 201811:06 amRNSBlock listing Interim Review
14th May 201810:45 amRNSDirector/PDMR Shareholding
9th May 20187:00 amRNSResult of AGM
25th Apr 20185:25 pmRNSDirector/PDMR Shareholding
5th Apr 201810:53 amRNSTotal Voting Rights
4th Apr 20189:00 amRNSNotice of AGM
19th Mar 201810:38 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
2nd Mar 20184:51 pmRNSStatement re change of website address
19th Feb 20189:16 amRNSBlock listing Interim Review
2nd Jan 201810:16 amRNSTotal Voting Rights
18th Dec 20179:36 amRNSBlock listing Interim Review
12th Dec 201712:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.